REGISTERED CHARITY NUMBER: 1188345
Report of the Trustees and
Unaudited Financial Statements
for the Year Ended 31 March 2023
for
British Oculoplastic Surgery Society
Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP
British Oculoplastic Surgery Society
Contents of the Financial Statements for the Year Ended 31 March 2023
|
Page |
Report of the Trustees |
1 to 2 |
Independent Examiner's Report |
3 |
Statement of Financial Activities |
4 |
Balance Sheet |
5 |
Notes to the Financial Statements |
6 to 10 |
Detailed Statement of Financial Activities |
11 to 12 |
British Oculoplastic Surgery Society
Report of the Trustees for the Year Ended 31 March 2023
Thetrusteespresenttheirreportwiththefinancialstatementsofthecharityforthe year
ended 31 March2023. The trusteeshave adoptedthe provisionsof Accountingand Reporting
byCharities:StatementofRecommendedPracticeapplicabletocharitiespreparing their
accountsinaccordancewiththeFinancialReportingStandardapplicableintheUK and
Republic of Ireland (FRS 102) (effective 1 January 2019).
ACHIEVEMENT AND PERFORMANCE
Charitable activities
Thecharityhasthislastyearbeenengagedinfarlessactivityduetothepandemic,but has
beenabletosetupaninternationalvirtualmeetingintheautumnof2020.Furthermore, it
has, as usual provided access to it's members to an online journal for educational purposes.
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
ThecharityiscontrolledbyitsgoverningconstitutionandisaCharitable Incorporated
Organisation, registered on 4 March 2020 with the registered charity number 1188345.
Risk management
Thetrusteesregularlyfulfiltheirdutyto identifyandreviewtherisksto whichthecharity is
exposedandtoensureappropriatecontrolsareinplacetoprovidereasonable assurance
against fraud and other risks.
Reserves
Thetrusteesregularlyreviewthelevelofreservesheldagainstexpectedexpenditure. The
trusteesareconfidentthatthecurrentlevelofreservesallowsthecharitytooperatein line
with its objectives.
REFERENCE AND ADMINISTRATIVE DETAILS
Registered Charity number
1188345
Principal address
c/o The Royal College of Ophthalmologist
18 Stephenson Way
London
NW1 2HD
Trustees
Ms C Jones President
C J Vize Secretary
T T Q Reuser Treasurer
D Verity
Page 1
British Oculoplastic Surgery Society
Report of the Trustees for the Year Ended 31 March 2023
REFERENCE AND ADMINISTRATIVE DETAILS
Independent Examiner
Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP
Approved by order of the board of trustees on 13 December 2023 and signed on its behalf by:
Trustee
Page 2
Independent Examiner's Report to the Trustees of
British Oculoplastic Surgery Society
Independent examiner's report to the trustees of British Oculoplastic Surgery Society
IreporttothecharitytrusteesonmyexaminationoftheaccountsofBritish Oculoplastic
Surgery Society (the Trust) for the year ended 31 March 2023.
Responsibilities and basis of report
As the charitytrusteesof the Trustyou are responsiblefor the preparationof the accounts in
accordance with the requirements of the Charities Act 2011 ('the Act').
I reportin respectof my examinationof the Trust'saccountscarriedout under Section145 of
theAct and in carryingout my examinationI havefollowedall applicableDirectionsgiven by
the Charity Commission under Section 145(5)(b) of the Act.
Independent examiner's statement
Ihavecompletedmyexamination.Iconfirmthatnomaterialmattershavecometo my
attentioninconnectionwiththeexaminationgivingmecausetobelievethatinany material
respect:
1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.
Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwith the
examinationtowhichattentionshouldbedrawninthisreportinordertoenablea proper
understanding of the accounts to be reached.
Stanbridge Associates Limited
Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP
Date: .............................................
Page 3
British Oculoplastic Surgery Society
Statement of Financial Activities for the Year Ended 31 March 2023
Notes
INCOME AND ENDOWMENTS FROM
Donations and legacies
Other trading activities
2
Investment income
3
Total
EXPENDITURE ON
Charitable activities
GENERAL
NET INCOME
RECONCILIATION OF FUNDS
Total funds brought forward
TOTAL FUNDS CARRIED FORWARD |
2023
Unrestricted
fund
£
214,558
17,624
-
232,182
181,714
50,468
315,638
366,106 |
2022
Total
funds
£
66,757
6,000
19 |
|
|
72,776 |
|
|
31,641 |
|
|
41,135
275,367 |
|
|
316,502 |
The notes form part of these financial statements
Page 4
British Oculoplastic Surgery Society
Balance Sheet 31 March 2023
Notes
CURRENT ASSETS
Cash at bank
CREDITORS
Amounts falling due within one year
6
NET CURRENT ASSETS
TOTAL ASSETS LESS CURRENT
LIABILITIES
NET ASSETS
FUNDS
7
Unrestricted funds
TOTAL FUNDS |
2023
Unrestricted
fund
£
365,902
(660)
365,242
365,242
365,242
365,242
365,242 |
2022
Total
funds
£
316,268
(630)
315,638
315,638
315,638
315,638
315,638 |
|
|
|
The financialstatementswere approvedby the Board of Trusteesand authorisedfor issue on
13 December 2023 and were signed on its behalf by:
Trustee
The notes form part of these financial statements
Page 5
British Oculoplastic Surgery Society
Notes to the Financial Statements for the Year Ended 31 March 2023
1. ACCOUNTING POLICIES
Basis of preparing the financial statements
Thefinancialstatementsofthecharity,whichisapublicbenefitentityunderFRS 102,
havebeenpreparedinaccordancewiththeCharitiesSORP(FRS102)'Accounting and
ReportingbyCharities:StatementofRecommendedPracticeapplicableto charities
preparingtheiraccountsinaccordancewiththeFinancialReporting Standard
applicableintheUKandRepublicofIreland(FRS102)(effective1January 2019)',
FinancialReportingStandard102'TheFinancialReportingStandardapplicablein the
UKandRepublicofIreland'andtheCharitiesAct2011.Thefinancialstatements have
been prepared under the historical cost convention.
Income
AllincomeisrecognisedintheStatementofFinancialActivitiesoncethecharity has
entitlementto the funds,it is probablethatthe incomewill be receivedand the amount
can be measured reliably.
Expenditure
Liabilitiesarerecognisedasexpenditureassoonasthereisalegalor constructive
obligationcommittingthecharitytothatexpenditure,itisprobablethatatransfer of
economicbenefitswillberequiredinsettlementandtheamountoftheobligation can
bemeasuredreliably.Expenditureisaccountedforonanaccrualsbasisandhas been
classifiedunderheadingsthataggregateallcostrelatedtothecategory.Where costs
cannotbedirectlyattributedtoparticularheadingstheyhavebeenallocated to
activities on a basis consistent with the use of resources.
Taxation
The charity is exempt from tax on its charitable activities.
Fund accounting
Unrestrictedfundscanbeusedinaccordancewiththecharitableobjectivesat the
discretion of the trustees.
Restrictedfundscanonlybeusedforparticularrestrictedpurposeswithinthe objects
of thecharity.Restrictionsarisewhenspecifiedby thedonoror whenfundsare raised
for particular restricted purposes.
Furtherexplanationofthenatureandpurposeofeachfundisincludedinthenotes to
the financial statements.
continued...
Page 6
British Oculoplastic Surgery Society
Notes to the Financial Statements - continued for the Year Ended 31 March 2023
2. |
OTHER TRADING ACTIVITIES |
OTHER TRADING ACTIVITIES |
|
|
|
|
|
|
|
|
|
|
2023 |
2022 |
|
|
|
|
|
|
£ |
|
£ |
|
Sponsorships |
|
|
|
17,624 |
|
6,000 |
|
|
|
|
|
|
|
|
3. |
INVESTMENT INCOME |
|
|
|
|
|
|
|
|
|
|
|
2023 |
2022 |
|
|
|
|
|
|
£ |
|
£ |
|
Bank Interest |
|
|
|
- |
|
19 |
|
|
|
|
|
|
|
|
4. |
TRUSTEES' REMUNERATION AND BENEFITS |
|
|
|
|
|
|
|
There
were no trustees' |
remuneration |
or other |
benefits |
for the |
year |
ended |
|
31 March 2023 nor for the year ended 31 March 2022. |
|
|
|
|
|
|
|
Trustees' expenses |
|
|
|
|
|
|
|
|
|
|
|
2023 |
2022 |
|
|
|
|
|
|
£ |
|
£ |
|
Trustees' expenses |
|
|
|
- |
|
133 |
|
|
|
|
|
|
|
|
5. |
COMPARATIVES FOR THE STATEMENT OF |
|
FINANCIAL |
ACTIVITIES |
|
|
|
|
|
|
|
|
|
Unrestricted |
|
|
|
|
|
|
|
|
fund |
|
|
|
|
|
|
|
£ |
|
INCOME AND ENDOWMENTS FROM |
|
|
|
|
|
|
|
Donations and legacies |
|
|
|
|
66,757 |
|
|
Other trading activities |
|
|
|
|
|
6,000 |
|
Investment income |
|
|
|
|
|
19 |
|
Total |
|
|
|
|
72,776 |
|
|
EXPENDITURE ON |
|
|
|
|
|
|
|
Charitable activities |
|
|
|
|
|
|
|
GENERAL |
|
|
|
|
|
|
|
|
|
|
|
|
31,641 |
|
|
NET INCOME |
|
|
|
|
41,135 |
|
|
RECONCILIATION OF FUNDS |
|
|
|
|
|
|
|
Total funds brought forward |
|
|
|
|
275,367 |
|
continued...
Page 7
British Oculoplastic Surgery Society
Notes to the Financial Statements - continued for the Year Ended 31 March 2023
5. |
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued |
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued |
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued |
COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued |
|
|
|
|
Unrestricted |
|
|
|
|
fund |
|
|
|
|
£ |
|
TOTAL FUNDS CARRIED |
|
|
|
|
FORWARD |
|
|
316,502 |
|
|
|
|
|
6. |
CREDITORS: AMOUNTS FALLING DUE |
WITHIN ONE YEAR |
|
|
|
|
|
2023 |
2022 |
|
|
|
£ |
£ |
|
Other creditors |
|
660 |
630 |
7. |
MOVEMENT IN FUNDS |
|
|
|
|
|
|
Net |
|
|
|
|
movement |
At |
|
|
At 1.4.22 |
in funds |
31.3.23 |
|
|
£ |
£ |
£ |
|
Unrestricted funds |
|
|
|
|
General fund |
315,638 |
49,604 |
365,242 |
|
TOTAL FUNDS |
315,638 |
49,604 |
365,242 |
|
|
|
|
|
|
Net movement in funds, included in the above are as follows: |
|
|
|
|
|
Incoming |
Resources |
Movement |
|
|
resources |
expended |
in funds |
|
|
£ |
£ |
£ |
|
Unrestricted funds |
|
|
|
|
General fund |
232,182 |
(182,578) |
49,604 |
|
TOTAL FUNDS |
232,182 |
(182,578) |
49,604 |
continued...
Page 8
British Oculoplastic Surgery Society
Notes to the Financial Statements - continued for the Year Ended 31 March 2023
7. MOVEMENT IN FUNDS - continued
Comparatives for movement in funds
Unrestricted funds
General fund
TOTAL FUNDS |
At 1.4.21
£
275,367
275,367 |
Net
movement
in funds
£
40,271
40,271 |
At
31.3.22
£
315,638 |
|
|
|
315,638 |
Comparative net movement in funds, included in the above are as follows:
Unrestricted funds
General fund
TOTAL FUNDS |
Incoming
resources
£
72,776
72,776 |
Resources
Movement
expended
in funds
£
£
(32,505)
40,271
(32,505)
40,271 |
|
|
|
A current year 12 months and prior year 12 months combined position is as follows:
Unrestricted funds
General fund
TOTAL FUNDS |
At 1.4.21
£
275,367
275,367 |
Net
movement
in funds
£
89,875
89,875 |
At
31.3.23
£
365,242 |
|
|
|
365,242 |
continued...
Page 9
British Oculoplastic Surgery Society
Notes to the Financial Statements - continued for the Year Ended 31 March 2023
7. MOVEMENT IN FUNDS - continued
A currentyear12 monthsandprioryear12 monthscombinednetmovementin funds,
included in the above are as follows:
Unrestricted funds
General fund
TOTAL FUNDS |
Incoming
resources
£
304,958
304,958 |
Resources
expended
£
(215,083)
(215,083) |
Movement
in funds
£
89,875
89,875 |
|
|
|
|
8. RELATED PARTY DISCLOSURES
There were no related party transactions for the year ended 31 March 2023.
Page 10
British Oculoplastic Surgery Society
Detailed Statement of Financial Activities
for the Year Ended 31 March 2023
INCOME AND ENDOWMENTS
Donations and legacies
Membership fees
Other trading activities
Sponsorships
Investment income
Bank Interest
Total incoming resources
EXPENDITURE
Charitable activities
Trustees' expenses
Executive meetings
Venue hire
Meeting organisation
Audiovisual
Event insurance
Support costs
Management
Advertising
Digital agency fees
Finance
Postage and stationery
Computer sundries
Bank charges |
2023
£
214,558
17,624
-
232,182
-
49,110
36,010
29,477
40,988
915
156,500
-
14,443
14,443
2,424
1,056
2,997
6,477 |
2022
£
66,757
6,000
19 |
|
|
72,776
133
78
4,380
3,738
-
- |
|
|
8,329
1,150
15,600 |
|
|
16,750
-
-
732 |
|
|
732 |
This page does not form part of the statutory financial statements
Page 11
British Oculoplastic Surgery Society
Detailed Statement of Financial Activities for the Year Ended 31 March 2023
Detailed Statement of Financial Activities
for the Year Ended 31 March 2023 |
|
|
Finance
Other
Subscriptions
Governance costs
Accountancy and legal fees
Total resources expended
Net income |
2023
£
3,634
660
181,714
50,468 |
2022
£
4,600
1,230 |
|
|
31,641 |
|
|
41,135 |
This page does not form part of the statutory financial statements
Page 12